The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...

HeartBeam has submitted a 510 (k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

The Company believes the study's findings support the clinical equivalence of HeartBeam's synthesized 12-lead ECG where the leads are similar to standard 12-lead ECGs for rhythm and arrhythmia ...

Electrocardiogram tests may someday be used with an artificial intelligence (AI) model to detect premature aging and ...

Electrocardiogram tests – which measure the heart's electrical activity – could someday be paired with an artificial ...

An artificial intelligence (AI) model designed to predict a person's biological age (age of body cells and tissues) based on electrocardiogram (ECG) data found a strong association between ECG-age and ...

Electrocardiogram (ECG) tests could potentially be used alongside an artificial intelligence (AI) model to detect premature ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

One explanation for the findings is that ECG data can help to predict the risk of stroke, which can contribute to age-related ...

An artificial intelligence (AI) model designed to predict a person's biological age (age of body cells and tissues) based on ...